Bridgebio Pharma Stock Technical Analysis
BBIO Stock | USD 25.03 0.43 1.69% |
As of the 25th of April, BridgeBio Pharma shows the Risk Adjusted Performance of (0.08), mean deviation of 2.63, and Standard Deviation of 3.56. BridgeBio Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for BridgeBio Pharma, which can be compared to its peers. Please confirm BridgeBio Pharma coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and skewness to decide if BridgeBio Pharma is priced correctly, providing market reflects its regular price of 25.03 per share. Given that BridgeBio Pharma has information ratio of (0.16), we suggest you to validate BridgeBio Pharma's prevailing market performance to make sure the company can sustain itself at a future point.
BridgeBio Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BridgeBio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BridgeBioBridgeBio |
BridgeBio Pharma Analyst Consensus
Target Price | Advice | # of Analysts | |
46.4 | Strong Buy | 13 | Odds |
Most BridgeBio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BridgeBio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BridgeBio Pharma, talking to its executives and customers, or listening to BridgeBio conference calls.
BridgeBio Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BridgeBio Pharma Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BridgeBio Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
BridgeBio Pharma Trend Analysis
Use this graph to draw trend lines for BridgeBio Pharma. You can use it to identify possible trend reversals for BridgeBio Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BridgeBio Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.BridgeBio Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BridgeBio Pharma applied against its price change over selected period. The best fit line has a slop of 0.18 , which may suggest that BridgeBio Pharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1293.5, which is the sum of squared deviations for the predicted BridgeBio Pharma price change compared to its average price change.About BridgeBio Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BridgeBio Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BridgeBio Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BridgeBio Pharma price pattern first instead of the macroeconomic environment surrounding BridgeBio Pharma. By analyzing BridgeBio Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BridgeBio Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BridgeBio Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2023 | 2024 (projected) | Dividend Yield | 0.001587 | 0.001428 | 0.001357 | Price To Sales Ratio | 34.54 | 706.43 | 741.75 |
BridgeBio Pharma April 25, 2024 Technical Indicators
Most technical analysis of BridgeBio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BridgeBio from various momentum indicators to cycle indicators. When you analyze BridgeBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.08) | |||
Market Risk Adjusted Performance | (0.16) | |||
Mean Deviation | 2.63 | |||
Coefficient Of Variation | (730.54) | |||
Standard Deviation | 3.56 | |||
Variance | 12.71 | |||
Information Ratio | (0.16) | |||
Jensen Alpha | (0.75) | |||
Total Risk Alpha | (0.99) | |||
Treynor Ratio | (0.17) | |||
Maximum Drawdown | 23.35 | |||
Value At Risk | (5.39) | |||
Potential Upside | 4.33 | |||
Skewness | 0.682 | |||
Kurtosis | 3.5 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BridgeBio Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for BridgeBio Stock analysis
When running BridgeBio Pharma's price analysis, check to measure BridgeBio Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BridgeBio Pharma is operating at the current time. Most of BridgeBio Pharma's value examination focuses on studying past and present price action to predict the probability of BridgeBio Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BridgeBio Pharma's price. Additionally, you may evaluate how the addition of BridgeBio Pharma to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is BridgeBio Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BridgeBio Pharma. If investors know BridgeBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BridgeBio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Revenue Per Share 0.057 | Quarterly Revenue Growth (0.07) | Return On Assets (0.64) | Return On Equity (17.90) |
The market value of BridgeBio Pharma is measured differently than its book value, which is the value of BridgeBio that is recorded on the company's balance sheet. Investors also form their own opinion of BridgeBio Pharma's value that differs from its market value or its book value, called intrinsic value, which is BridgeBio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BridgeBio Pharma's market value can be influenced by many factors that don't directly affect BridgeBio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BridgeBio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if BridgeBio Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BridgeBio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.